The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia

Creative Commons License

ERKUT N., MENTEŞE A., Ozbas H. M., Ermantas N., Sumer A., ÖREM A., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.2, ss.135-140, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2014.0405
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.135-140
  • Anahtar Kelimeler: Soluble urokinase plasminogen activator receptor, Acute myeloid leukemia, Prognosis, CANCER PATIENTS, COLORECTAL-CANCER, OVARIAN-CANCER, PLASMA, CELLS, TUMOR, SUPAR, EXPRESSION, SYSTEM, FORM
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objective: The soluble urokinase plasminogen activator receptor (suPAR) is a soluble form of the urokinase plasminogen activator receptor expressed in various immune and cancer cells. The levels of suPAR have been demonstrated to correlate with prognosis in various cancers. This study was intended to investigate serum suPAR levels and their effect on prognosis in patients with acute myeloid leukemia (AML).